Make a Gift
A dedicated donation supporting ovarian and related gynecologic cancers research is a perfect way to honor or remember your loved one.
Read more about Make a Gift Accelerate our progress toward a cure with a dedicated donation
Donate in Honor of Someone You Love
Honor a Loved One
Every day, patients and families around the world are impacted by ovarian cancer. And every day, OCRA-funded scientists are working on the most promising research to create new, more effective treatments, achieve desperately needed breakthroughs, and get closer to a cure. Honor or remember a loved one by giving a dedicated donation.
Create or Donate to a Tribute Page
Transform devotion into action by fundraising in honor or in memory of someone special or donating to an existing page.
Read more about Create or Donate to a Tribute Page Pay tribute
Share Your Photos and Story
Spread the word and raise awareness by sharing your or your loved one’s experience with ovarian and related gynecologic cancers.
Related Topics
OCRA Sponsors NCCN 2025 Guidelines for Cervical, Ovarian, and Uterine Cancer Patients
This article was updated in October 2025 to reflect NCCN’s release of the 2025 Guidelines for Uterine Cancer Patients. OCRA is a proud sponsor of the 2025 Patient Guidelines for Cervical, Ovarian, and Uterine Cancer. We believe ensuring access to clear, understandable information is critical. NCCN provides wonderful guides for anyone newly diagnosed to help … Continued
OCRA’s Survivors Teaching Students Program Spotlighted by Fort Worth Star-Telegram
In a recent article for the Fort Worth Star-Telegram, Jeff Guttenfelder spoke with journalist Ciara McCarthy about losing his late wife, Ni, to ovarian cancer, and how he is channeling his grief into action through participation in OCRA’s Survivors Teaching Students program. Read the article “Fort Worth man’s wife died of ovarian cancer” in the … Continued
KVIA-TV ABC-7 Features OCRA-Funded Research Developing Nanotechnology for Ovarian Cancer Detection
KVIA-TV ABC-7 News El Paso recently spotlighted the groundbreaking work of OCRA-funded researcher Daniel Heller, PhD of Memorial Sloan Kettering Cancer Center, whose research lab is working to develop a liquid biopsy that uses nanotechnology and artificial intelligence (AI) to detect ovarian cancer earlier. We’re developing a liquid biopsy that uses nano sensors and AI … Continued